Evexia Lifecare Limited shareholders approved all ten resolutions at the 35th Annual General Meeting held on September 30, 2026, with over 99.9% of valid votes cast in favor.

The meeting, conducted via video conferencing, sought approval for material related party transactions with eight entities and the adoption of audited financial statements for FY26. Jayesh Raichandbhai Thakkar, Managing Director and Chairperson, presided over the session which concluded at 3:15 pm.

Key Agenda Items

The Board placed several items before shareholders for approval through remote e-voting. These included the adoption of standalone and consolidated audited financial statements for FY26 and the re-appointment of Mr. Hasmukhbhai Dhanjibhai Thakkar as a director retiring by rotation.

A significant portion of the agenda focused on approving material related party transactions. The company sought ordinary resolutions to approve dealings with the following entities:

• Kavir Edible Oil Limited
• Kavir Cable Private Limited
• Evexia Lifecare Africa Limited
• Diponed Research International Private Limited
• Diponed Bio Private Limited
• Vittals Medicare Private Limited
• Evexia PAN Africa Limited
• Heemsol Energy System Private Limited

Governance and Attendance

The following directors and key managerial personnel were present at the meeting:

Brajesh Gupta served as the Secretarial Auditor and Scrutinizer, while Tejas Soni attended as the Statutory Auditor. The Chairman confirmed that the requisite quorum was present to conduct the proceedings.

Voting Results

Shareholders cast votes electronically on all resolutions. No votes were cast during the live AGM session; all voting occurred via remote e-voting prior to the meeting. The scrutinizer's report confirmed that all resolutions passed with a substantial majority.

The consolidated results were announced following the scrutiny process completed by Brajesh Gupta & Co. The results are displayed at the registered office and disseminated on the company's website and NSDL platform.

Evexia Lifecare Limited saw its promoter group increase its stake following an open market purchase of 66,25,997 equity shares. The transaction was executed by Shree Saibaba Exim Private Limited on September 30, 2026.

This acquisition raises the promoter group's holding to 13,41,75,824 shares, representing 7.147% of the company's total voting capital. Prior to this transaction, the holding stood at 12,75,49,827 shares, or 6.794% of the total share capital.

Transaction details

The disclosure was filed under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The trade was conducted entirely through the open market mechanism on the BSE.

The company's total equity share capital remained unchanged at 187,73,28,995 shares with a face value of ₹1 each. There were no encumbrances, warrants, or convertible securities involved in this specific transaction.

What the numbers show

The incremental purchase of 66,25,997 shares represents a 0.352% addition to the total share capital. This modest but consistent accumulation by a promoter group entity signals continued confidence in the stock at current valuation levels. The shift from 6.794% to 7.147% marks a crossing of the 7% threshold for this specific entity, although it remains below the 5% substantial acquisition threshold that triggers more frequent public disclosures, indicating this is likely part of ongoing portfolio management rather than a sudden strategic takeover attempt.

The disclosure was signed by Artiben Jayeshbhai Thakkar, Director of Shree Saibaba Exim Private Limited, and intimated to the company on October 1, 2026.